Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants

Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, David Ross Darley, Deepti Pilli, Daniele Vitale, Vera Merheb, Fiona X. Z. Lee, View ORCID ProfilePhilip Cunningham, View ORCID ProfileGregory J. Walker, David A. Brown, View ORCID ProfileWilliam D. Rawlinson, Sonia R. Isaacs, Vennila Mathivanan, Markus Hoffman, Stefan Pöhlmann, Dominic E. Dwyer, View ORCID ProfileRebeca Rockett, View ORCID ProfileVitali Sintchenko, Veronica C. Hoad, David O. Irving, Gregory J. Dore, View ORCID ProfileIain B. Gosbell, View ORCID ProfileAnthony D. Kelleher, Gail V. Matthews, View ORCID ProfileFabienne Brilot, View ORCID ProfileStuart G Turville
doi: https://doi.org/10.1101/2020.12.19.20248567
Fiona Tea
1Brain Autoimmunity Group, Kids Neuroscience Centre, Kids Research at the Children’s Hospital at Westmead, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Ospina Stella
2The Kirby Institute, The University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anupriya Aggarwal
2The Kirby Institute, The University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Ross Darley
3St Vincent’s Hospital, Sydney, New South Wales, Australia
4School of Medicine, St Vincent’s Clinical School, The University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deepti Pilli
1Brain Autoimmunity Group, Kids Neuroscience Centre, Kids Research at the Children’s Hospital at Westmead, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniele Vitale
5Westmead Institute for Medical Research, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vera Merheb
1Brain Autoimmunity Group, Kids Neuroscience Centre, Kids Research at the Children’s Hospital at Westmead, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fiona X. Z. Lee
1Brain Autoimmunity Group, Kids Neuroscience Centre, Kids Research at the Children’s Hospital at Westmead, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Cunningham
6St Vincent’s Applied Medical Research, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Philip Cunningham
Gregory J. Walker
7New South Wales Health Pathology, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gregory J. Walker
David A. Brown
5Westmead Institute for Medical Research, Sydney, New South Wales, Australia
7New South Wales Health Pathology, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William D. Rawlinson
7New South Wales Health Pathology, Sydney, Australia
8School of Medical Sciences, Biotechnology and Biomolecular Sciences, and School of Women’s and Children’s Health, The University of New South Wales Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for William D. Rawlinson
Sonia R. Isaacs
7New South Wales Health Pathology, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vennila Mathivanan
2The Kirby Institute, The University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Hoffman
9German Primate Center Infection Biology Unit, Georg-August-University, Göttingen, Germany
10Faculty of Biology and Psychology, Georg-August-University, Göttingen, Göttingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Pöhlmann
9German Primate Center Infection Biology Unit, Georg-August-University, Göttingen, Germany
10Faculty of Biology and Psychology, Georg-August-University, Göttingen, Göttingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominic E. Dwyer
7New South Wales Health Pathology, Sydney, Australia
11Centre for Infectious Diseases & Microbiology - Public Health, New South Wales Health Pathology - Institute of Clinical Pathology & Medical Research (ICPMR), Westmead, Sydney, New South Wales, Australia
12Marie Bashir Institute for Biosecurity, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebeca Rockett
11Centre for Infectious Diseases & Microbiology - Public Health, New South Wales Health Pathology - Institute of Clinical Pathology & Medical Research (ICPMR), Westmead, Sydney, New South Wales, Australia
12Marie Bashir Institute for Biosecurity, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rebeca Rockett
Vitali Sintchenko
7New South Wales Health Pathology, Sydney, Australia
11Centre for Infectious Diseases & Microbiology - Public Health, New South Wales Health Pathology - Institute of Clinical Pathology & Medical Research (ICPMR), Westmead, Sydney, New South Wales, Australia
12Marie Bashir Institute for Biosecurity, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
13Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vitali Sintchenko
Veronica C. Hoad
14Australian Red Cross Lifeblood, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David O. Irving
14Australian Red Cross Lifeblood, Melbourne, Victoria, Australia
15Faculty of Health, University of Technology, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory J. Dore
2The Kirby Institute, The University of New South Wales, Sydney, New South Wales, Australia
3St Vincent’s Hospital, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iain B. Gosbell
14Australian Red Cross Lifeblood, Melbourne, Victoria, Australia
16School of Medicine, Western Sydney University, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Iain B. Gosbell
Anthony D. Kelleher
2The Kirby Institute, The University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anthony D. Kelleher
Gail V. Matthews
2The Kirby Institute, The University of New South Wales, Sydney, New South Wales, Australia
3St Vincent’s Hospital, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabienne Brilot
1Brain Autoimmunity Group, Kids Neuroscience Centre, Kids Research at the Children’s Hospital at Westmead, Sydney, New South Wales, Australia
12Marie Bashir Institute for Biosecurity, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
13Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
17School of Medical Sciences, Discipline of Applied Medical Science, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
18Brain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fabienne Brilot
Stuart G Turville
2The Kirby Institute, The University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stuart G Turville
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The SARS-CoV-2 antibody neutralization response and its evasion by emerging viral variants are unknown. Antibody immunoreactivity against SARS-CoV-2 antigens and Spike variants, inhibition of Spike-driven virus-cell fusion, and infectious SARS-CoV-2 neutralization were characterized in 807 serial samples from 233 RT-PCR-confirmed COVID-19 individuals with detailed demographics and followed up to seven months. A broad and sustained polyantigenic immunoreactivity against SARS-CoV-2 Spike, Membrane, and Nucleocapsid proteins, along with high viral neutralization were associated with COVID-19 severity. A subgroup of ‘high responders’ maintained high neutralizing responses over time, representing ideal convalescent plasma therapy donors. Antibodies generated against SARS-CoV-2 during the first COVID-19 wave had reduced immunoreactivity and neutralization potency to emerging Spike variants. Accurate monitoring of SARS-CoV-2 antibody responses would be essential for selection of optimal plasma donors and vaccine monitoring and design.

One Sentence Summary Neutralizing antibody responses to SARS-CoV-2 are sustained, associated with COVID19 severity, and evaded by emerging viral variants

Competing Interest Statement

FB has received honoraria from Biogen Idec and Merck Serono as invited speaker. All other authors declare no competing interests.

Funding Statement

This work was supported by Snow Medical (Australia), The University of New South Wales Rapid Response grant (Australia), the University of Sydney Research Excellence Initiative grant (Australia), and the MRRF NHRMC COVID-19 grant. The Australian Governments fund Australian Red Cross Lifeblood for the provision of blood, blood products, and services for the Australian community.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics approval for this study was granted by St Vincents Hospital (2020/ETH00964) and Lifeblood (30042020) Research Ethics Committees. Written consent was obtained from all ADAPT patients. In LIFE, the donor consent form included a statement that blood donation may be used in research.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Figure 5 has been updated with panel H. Line 306: Text has been added to describe Fig 5H in Results. Line 396: the discussion has been edited Line 430-432: the discussion has been edited. Line 625-628: Addition of Ref 30 and 31: these two recent studies highlight the benefit of convalescent plasma at high titers administered early. Line 737-736: the Figure 5 legend has been edited.

Data Availability

Correspondence and requests for data should be addressed to FB and may be limited due to ethical considerations. Plasmids transfer should be obtained through a MTA.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 23, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants
Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, David Ross Darley, Deepti Pilli, Daniele Vitale, Vera Merheb, Fiona X. Z. Lee, Philip Cunningham, Gregory J. Walker, David A. Brown, William D. Rawlinson, Sonia R. Isaacs, Vennila Mathivanan, Markus Hoffman, Stefan Pöhlmann, Dominic E. Dwyer, Rebeca Rockett, Vitali Sintchenko, Veronica C. Hoad, David O. Irving, Gregory J. Dore, Iain B. Gosbell, Anthony D. Kelleher, Gail V. Matthews, Fabienne Brilot, Stuart G Turville
medRxiv 2020.12.19.20248567; doi: https://doi.org/10.1101/2020.12.19.20248567
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants
Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, David Ross Darley, Deepti Pilli, Daniele Vitale, Vera Merheb, Fiona X. Z. Lee, Philip Cunningham, Gregory J. Walker, David A. Brown, William D. Rawlinson, Sonia R. Isaacs, Vennila Mathivanan, Markus Hoffman, Stefan Pöhlmann, Dominic E. Dwyer, Rebeca Rockett, Vitali Sintchenko, Veronica C. Hoad, David O. Irving, Gregory J. Dore, Iain B. Gosbell, Anthony D. Kelleher, Gail V. Matthews, Fabienne Brilot, Stuart G Turville
medRxiv 2020.12.19.20248567; doi: https://doi.org/10.1101/2020.12.19.20248567

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (217)
  • Allergy and Immunology (496)
  • Anesthesia (106)
  • Cardiovascular Medicine (1112)
  • Dentistry and Oral Medicine (197)
  • Dermatology (141)
  • Emergency Medicine (275)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (508)
  • Epidemiology (9807)
  • Forensic Medicine (5)
  • Gastroenterology (482)
  • Genetic and Genomic Medicine (2335)
  • Geriatric Medicine (223)
  • Health Economics (464)
  • Health Informatics (1569)
  • Health Policy (738)
  • Health Systems and Quality Improvement (609)
  • Hematology (238)
  • HIV/AIDS (508)
  • Infectious Diseases (except HIV/AIDS) (11674)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2162)
  • Nursing (134)
  • Nutrition (340)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (520)
  • Oncology (1187)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (221)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (314)
  • Pediatrics (700)
  • Pharmacology and Therapeutics (303)
  • Primary Care Research (268)
  • Psychiatry and Clinical Psychology (2196)
  • Public and Global Health (4694)
  • Radiology and Imaging (786)
  • Rehabilitation Medicine and Physical Therapy (459)
  • Respiratory Medicine (625)
  • Rheumatology (276)
  • Sexual and Reproductive Health (227)
  • Sports Medicine (214)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)